These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

616 related items for PubMed ID: 16221962

  • 1. Toxic effects of fumonisin in mouse liver are independent of the peroxisome proliferator-activated receptor alpha.
    Voss KA, Liu J, Anderson SP, Dunn C, Miller JD, Owen JR, Riley RT, Bacon CW, Corton JC.
    Toxicol Sci; 2006 Jan; 89(1):108-19. PubMed ID: 16221962
    [Abstract] [Full Text] [Related]

  • 2. The role of tumor necrosis factor alpha and the peroxisome proliferator-activated receptor alpha in modulating the effects of fumonisin in mouse liver.
    Voss KA, Riley R, Dunn C, Christopher Corton J.
    Toxicology; 2006 May 15; 222(3):165-74. PubMed ID: 16574297
    [Abstract] [Full Text] [Related]

  • 3. Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.
    Pogribny IP, Tryndyak VP, Woods CG, Witt SE, Rusyn I.
    Mutat Res; 2007 Dec 01; 625(1-2):62-71. PubMed ID: 17586532
    [Abstract] [Full Text] [Related]

  • 4. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase.
    Woods CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn I.
    Toxicol Sci; 2007 Aug 01; 98(2):366-74. PubMed ID: 17483499
    [Abstract] [Full Text] [Related]

  • 5. Time course investigation of PPARalpha- and Kupffer cell-dependent effects of WY-14,643 in mouse liver using microarray gene expression.
    Woods CG, Kosyk O, Bradford BU, Ross PK, Burns AM, Cunningham ML, Qu P, Ibrahim JG, Rusyn I.
    Toxicol Appl Pharmacol; 2007 Dec 15; 225(3):267-77. PubMed ID: 17950772
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Response of growing swine to dietary exposure to pure fumonisin B1 during an eight-week period: growth and clinical parameters.
    Rotter BA, Thompson BK, Prelusky DB, Trenholm HL, Stewart B, Miller JD, Savard ME.
    Nat Toxins; 1996 Dec 15; 4(1):42-50. PubMed ID: 8680753
    [Abstract] [Full Text] [Related]

  • 9. Lupus-prone NZBWF1/J mice, defective in cytokine signaling, are resistant to fumonisin hepatotoxicity despite accumulation of liver sphinganine.
    Sharma RP, He Q, Riley RT.
    Toxicology; 2005 Dec 15; 216(1):59-71. PubMed ID: 16159691
    [Abstract] [Full Text] [Related]

  • 10. Carcinogenicity and mechanism of action of fumonisin B1: a mycotoxin produced by Fusarium moniliforme (= F. verticillioides).
    Voss KA, Howard PC, Riley RT, Sharma RP, Bucci TJ, Lorentzen RJ.
    Cancer Detect Prev; 2002 Dec 15; 26(1):1-9. PubMed ID: 12088196
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of tumor necrosis factor alpha signaling by anti-tumor necrosis factor alpha antibodies and pentoxifylline is unable to prevent fumonisin hepatotoxicity in mice.
    He Q, Sharma RP.
    Toxicon; 2005 Sep 15; 46(4):404-13. PubMed ID: 16054185
    [Abstract] [Full Text] [Related]

  • 12. Elevation of sphingoid base 1-phosphate as a potential contributor to hepatotoxicity in fumonisin B1-exposed mice.
    Kim DH, Lee YS, Lee YM, Oh S, Yun YP, Yoo HS.
    Arch Pharm Res; 2007 Aug 15; 30(8):962-9. PubMed ID: 17879749
    [Abstract] [Full Text] [Related]

  • 13. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
    Bhandari N, He Q, Sharma RP.
    Toxicology; 2001 Aug 28; 165(2-3):195-204. PubMed ID: 11522378
    [Abstract] [Full Text] [Related]

  • 14. Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies).
    Natl Toxicol Program Tech Rep Ser; 2001 Dec 28; (496):1-352. PubMed ID: 11852482
    [Abstract] [Full Text] [Related]

  • 15. Subchronic feeding study of the mycotoxin fumonisin B1 in B6C3F1 mice and Fischer 344 rats.
    Voss KA, Chamberlain WJ, Bacon CW, Herbert RA, Walters DB, Norred WP.
    Fundam Appl Toxicol; 1995 Jan 28; 24(1):102-10. PubMed ID: 7713333
    [Abstract] [Full Text] [Related]

  • 16. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase.
    Woods CG, Burns AM, Maki A, Bradford BU, Cunningham ML, Connor HD, Kadiiska MB, Mason RP, Peters JM, Rusyn I.
    Free Radic Biol Med; 2007 Feb 01; 42(3):335-42. PubMed ID: 17210446
    [Abstract] [Full Text] [Related]

  • 17. Activation of peroxisome proliferator-activated receptor alpha enhances apoptosis in the mouse liver.
    Xiao S, Anderson SP, Swanson C, Bahnemann R, Voss KA, Stauber AJ, Corton JC.
    Toxicol Sci; 2006 Aug 01; 92(2):368-77. PubMed ID: 16687391
    [Abstract] [Full Text] [Related]

  • 18. Subchronic toxic effects of Fusarium moniliforme and fumonisin B1 in rats and mice.
    Voss KA, Riley RT, Bacon CW, Chamberlain WJ, Norred WP.
    Nat Toxins; 1996 Aug 01; 4(1):16-23. PubMed ID: 8680749
    [Abstract] [Full Text] [Related]

  • 19. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
    Rosen MB, Das KP, Rooney J, Abbott B, Lau C, Corton JC.
    Toxicology; 2017 Jul 15; 387():95-107. PubMed ID: 28558994
    [Abstract] [Full Text] [Related]

  • 20. Comparative subchronic toxicity studies of nixtamalized and water-extracted Fusarium moniliforme culture material.
    Voss KA, Bacon CW, Meredith FI, Norred WP.
    Food Chem Toxicol; 1996 Jul 15; 34(7):623-32. PubMed ID: 8761355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.